GLP1RAs associated with reduced amputation rate and CV risk in diabetics: Study

The study titled, "Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors ...

Popular posts from this blog

How the timing of dinner and genetics affect individuals' blood sugar control - ScienceDaily

Coronapod: COVID and diabetes, what the science says - Nature

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating ...